Protagonist Therapeutics
PTGX
PTGX
77 hedge funds and large institutions have $165M invested in Protagonist Therapeutics in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 81 → 77 (-4)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Holders
77
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.41M | |
| 2 | +$3.56M | |
| 3 | +$1.54M | |
| 4 |
RI
RTW Investments
New York
|
+$1.41M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$599K |
Top Sellers
| 1 | -$3.56M | |
| 2 | -$1.76M | |
| 3 | -$1.06M | |
| 4 |
O
OrbiMed
New York
|
-$877K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$734K |